Equities

Metropolis Healthcare Ltd

METROPOLIS:NSI

Metropolis Healthcare Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)2,032.20
  • Today's Change-12.80 / -0.63%
  • Shares traded99.06k
  • 1 Year change+26.15%
  • Beta0.6964
Data delayed at least 15 minutes, as of Nov 14 2024 10:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,2431,0631,807
Total Receivables, Net1,3591,3171,484
Total Inventory428499547
Prepaid expenses705138
Other current assets, total589855
Total current assets3,1583,0273,931
Property, plant & equipment, net3,3603,1062,487
Goodwill, net4,5474,5474,547
Intangibles, net3,8633,7493,613
Long term investments591918
Note receivable - long term222833
Other long term assets196142166
Total assets15,55115,01615,303
LIABILITIES
Accounts payable9949411,032
Accrued expenses211207217
Notes payable/short-term debt000
Current portion long-term debt/capital leases7801,1231,373
Other current liabilities, total473379394
Total current liabilities2,4592,6503,015
Total long term debt1,1911,5412,413
Total debt1,9712,6643,786
Deferred income tax751782867
Minority interest312520
Other liabilities, total158136126
Total liabilities4,5895,1346,441
SHAREHOLDERS EQUITY
Common stock102102102
Additional paid-in capital1,5661,5661,564
Retained earnings (accumulated deficit)9,2598,1887,182
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total342613
Total equity10,9629,8828,862
Total liabilities & shareholders' equity15,55115,01615,303
Total common shares outstanding515151
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.